Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00512486 · ClinicalTrials.gov registry record · Phase 1
A Sequential Dose-Escalation Study in Subjects With Mild Asthma
A Phase 1 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT00512486 is a Phase 1 study that has completed, run by MedImmune. The registered enrollment target is 42 participants.
The verdict
NCT00512486, a Phase 1 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The primary objective of this study is to investigate the safety of administration of this drug by increasing doses to male and female adult subjects with mild asthma.
Interventions
- BIOLOGICAL MEDI-563
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00512486
The ClinicalTrials.gov registry entry for NCT00512486 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MEDI-563 is the first listed.
NCT00512486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00512486 about?
NCT00512486 is a clinical study titled "A Sequential Dose-Escalation Study in Subjects With Mild Asthma". The primary objective of this study is to investigate the safety of administration of this drug by increasing doses to male and female adult subjects with mild asthma.
What is the current status of trial NCT00512486?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2006-11. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00512486?
The interventions under investigation include: MEDI-563 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00512486?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.